Contact Us
EH
Clinical Trial
Study Title Conditions Interventions Locations
A Study of HSK29116 in Adults With Relapsed/Refractory B-cell Malignancies2
  • Relapsed/Refractory B-Cell Malignancies
  • Drug: HSK29116
    • One Clinical Research Perth, Australia
    • Woden Dermatology Phillip, Australia
    • NANFANG Hospital Guangzhou, Guangdong, China
    • (and 3 more...)